...
首页> 外文期刊>Journal of pain & palliative care pharmacotherapy >Opioid Prescribing Patterns and Costs in a Large Group of Patients in Colombia
【24h】

Opioid Prescribing Patterns and Costs in a Large Group of Patients in Colombia

机译:阿片类药物在哥伦比亚一大群患者中的规定模式和成本

获取原文
获取原文并翻译 | 示例
           

摘要

The potential for development of tolerance and dependence and the risk of side effects of opioids make it necessary to monitor their prescribing patterns in order to decrease the morbidity and mortality associated with their continued use. The objective of this study was to determine prescription patterns of opioid medication in a group of patients through a cross-sectional study on a population database of 3.5 million people. Patients with three months of continuous opioid use were identified. Pharmacological, co-medication and cost variables were analyzed. We conducted a multivariate analysis. A total of 7,457 patients were included; 72.1% were women, the mean age was 65.1 years, and 3.8% had a diagnosis of cancer. 10.2% of the patients received opioids in combination therapy. The most prescribed opioids were codeine (57.7%), tramadol (30.9%), and hydrocodone (10.4%). The great majority of patients (91.8%) received pharmacological co-medication with antihypertensive agents (54.4%), statins (38.2%) and acetaminophen (35.4%). The use of other analgesics such as acetaminophen (OR: 1.45, 95% CI: 1.22 -1.75) or nonsteroidal anti-inflammatory drugs (OR: 1.98, 95% CI: 1.60 -2.44) was associated with increased risk of receiving opioids in combination therapy. Prescribing habits of weak agonists and short-acting opioids predominate, mainly in monotherapy and at lower than recommended doses.
机译:耐受性和依赖性的潜力和阿片类药物副作用的风险使其有必要监测其处方模式,以降低与其继续使用相关的发病率和死亡率。本研究的目的是通过对350万人口数据库的横断面研究确定一组患者的阿片类药物的处方模式。鉴定了连续三个月的连续阿片类药物的患者。分析了药理学,共用和成本变量。我们进行了多变量分析。共有7,457名患者; 72.1%是女性,平均年龄为65.1岁,3.8%诊断癌症。 10.2%的患者接受联合治疗的阿片类药物。最具规定的阿片类药物是可待因(57.7%),曲马多(30.9%)和氢码(10.4%)。大多数患者(91.8%)接受了药理学共同用抗高血压剂(54.4%),毒素(38.2%)和乙酰氨酸(35.4%)。使用其他镇痛药,如乙酰氨基酚(或:1.45,95%CI:1.22 -1.75)或非甾体抗炎药(或:1.98,95%CI:1.60 -2.44)与组合接受阿片类药物的风险增加有关治疗。弱激动剂和短作用阿片类药物的规定习惯主要在单一疗法和低于推荐剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号